These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 37074676)

  • 1. Calcium phosphate microcrystallopathy as a paradigm of chronic kidney disease progression.
    Kuro-O M
    Curr Opin Nephrol Hypertens; 2023 Jul; 32(4):344-351. PubMed ID: 37074676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel assessments of systemic calcification propensity.
    Pasch A
    Curr Opin Nephrol Hypertens; 2016 Jul; 25(4):278-84. PubMed ID: 27228365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calciprotein particles: mineral behaving badly?
    Smith ER; Hewitson TD; Jahnen-Dechent W
    Curr Opin Nephrol Hypertens; 2020 Jul; 29(4):378-386. PubMed ID: 32404635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantification of Calciprotein Particles (CPPs) in Serum/Plasma Samples Using a Fluorescent Bisphosphonate.
    Miura Y; Kurosu H; Kuro-O M
    Methods Mol Biol; 2023; 2664():333-341. PubMed ID: 37423998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Klotho and calciprotein particles as therapeutic targets against accelerated ageing.
    Kuro-O M
    Clin Sci (Lond); 2021 Aug; 135(15):1915-1927. PubMed ID: 34374422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Magnesium and calciprotein particles in vascular calcification: the good cop and the bad cop.
    Zeper LW; de Baaij JHF
    Curr Opin Nephrol Hypertens; 2019 Jul; 28(4):368-374. PubMed ID: 31045659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and quantification of plasma calciprotein particles with distinct physical properties in patients with chronic kidney disease.
    Miura Y; Iwazu Y; Shiizaki K; Akimoto T; Kotani K; Kurabayashi M; Kurosu H; Kuro-O M
    Sci Rep; 2018 Jan; 8(1):1256. PubMed ID: 29352150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic Kidney Disease Circulating Calciprotein Particles and Extracellular Vesicles Promote Vascular Calcification: A Role for GRP (Gla-Rich Protein).
    Viegas CSB; Santos L; Macedo AL; Matos AA; Silva AP; Neves PL; Staes A; Gevaert K; Morais R; Vermeer C; Schurgers L; Simes DC
    Arterioscler Thromb Vasc Biol; 2018 Mar; 38(3):575-587. PubMed ID: 29301790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular Clearance and Biological Activity of Calciprotein Particles Depend on Their Maturation State and Crystallinity.
    Köppert S; Büscher A; Babler A; Ghallab A; Buhl EM; Latz E; Hengstler JG; Smith ER; Jahnen-Dechent W
    Front Immunol; 2018; 9():1991. PubMed ID: 30233585
    [No Abstract]   [Full Text] [Related]  

  • 10. Calciprotein Particle Synthesis Strategy Determines In Vitro Calcification Potential.
    Zeper LW; Smith ER; Ter Braake AD; Tinnemans PT; de Baaij JHF; Hoenderop JGJ
    Calcif Tissue Int; 2023 Jan; 112(1):103-117. PubMed ID: 36326853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Solving the insoluble: calciprotein particles mediate bulk mineral transport.
    Jahnen-Dechent W; Pasch A
    Kidney Int; 2023 Apr; 103(4):663-665. PubMed ID: 36948767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fetuin-A-containing calciprotein particles reduce mineral stress in the macrophage.
    Smith ER; Hanssen E; McMahon LP; Holt SG
    PLoS One; 2013; 8(4):e60904. PubMed ID: 23577176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liver and spleen predominantly mediate calciprotein particle clearance in a rat model of chronic kidney disease.
    Zeper LW; Bos C; Leermakers PA; Franssen GM; Raavé R; Hoenderop JGJ; de Baaij JHF
    Am J Physiol Renal Physiol; 2024 Apr; 326(4):F622-F634. PubMed ID: 38420675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Mineral metabolism and aging.].
    Kuro-O M
    Clin Calcium; 2019; 29(2):165-170. PubMed ID: 30679396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects for inflammatory responses by CPP with different colloidal properties in hemodialysis patients.
    Mukai H; Miura Y; Kotani K; Kotoda A; Kurosu H; Yamada T; Kuro-O M; Iwazu Y
    Sci Rep; 2022 Dec; 12(1):21856. PubMed ID: 36528732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biochemical transformation of calciprotein particles in uraemia.
    Smith ER; Hewitson TD; Hanssen E; Holt SG
    Bone; 2018 May; 110():355-367. PubMed ID: 29499417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of lanthanum carbonate on calciprotein particles in hemodialysis patients.
    Nakamura K; Nagata Y; Hiroyoshi T; Isoyama N; Fujikawa K; Miura Y; Matsuyama H; Kuro-O M
    Clin Exp Nephrol; 2020 Apr; 24(4):323-329. PubMed ID: 31875935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fetuin-A decrease induced by a low-protein diet enhances vascular calcification in uremic rats with hyperphosphatemia.
    Yamada S; Tokumoto M; Tsuruya K; Tatsumoto N; Noguchi H; Kitazono T; Ooboshi H
    Am J Physiol Renal Physiol; 2015 Oct; 309(8):F744-54. PubMed ID: 26180236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Daily variability in serum levels of calciprotein particles and their association with mineral metabolism parameters: A cross-sectional pilot study.
    Yamada H; Kuro-O M; Ishikawa SE; Funazaki S; Kusaka I; Kakei M; Hara K
    Nephrology (Carlton); 2018 Mar; 23(3):226-230. PubMed ID: 28052525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of lanthanum carbonate on serum calciprotein particles in patients with stage 3-4 CKD-results from a placebo-controlled randomized trial.
    Tiong MK; Smith ER; Pascoe EM; Elder GJ; Lioufas NM; Pedagogos E; Hawley CM; Valks A; Holt SG; Hewitson TD; Toussaint ND
    Nephrol Dial Transplant; 2023 Feb; 38(2):344-351. PubMed ID: 35212735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.